I-Mab Receives IND Approval for Phase 1 Clinical Trial of Bispecific Antibody TJ-CD4B in Solid Tumors in China

I Mab Receives Ind Approval For Phase 1 Clinical Trial Of Bispecific Antibody Tj Cd4b In Solid Tumors In China

Facebook Comments

Leave a Reply

CommentLuv badge